Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia.
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia. Leukemia. 2019 04; 33(4):884-892.
View in:
PubMed
subject areas
Adolescent
Adult
Antibodies, Monoclonal, Humanized
Antineoplastic Agents
Child
Child, Preschool
Drug Resistance, Neoplasm
Female
Humans
Male
Neoplasm Recurrence, Local
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Prognosis
Remission Induction
Retrospective Studies
Salvage Therapy
Survival Rate
Young Adult
authors with profiles
Jennifer L. McNeer